Viridian Therapeutics (VRDN) Earnings Date & Reports

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VRDN is expected to report earnings to rise 16.09% to -100 cents per share on August 06

Viridian Therapeutics VRDN Stock Earnings Reports

Q2'25

Est.

$-1.01

Q1'25

Beat

by $0.11

Q4'24

Beat

by $0.22

Q3'24

Missed

by $0.09

Q2'24

Missed

by $0.15

The last earnings report on May 06 showed earnings per share of -87 cents, beating the estimate of -98 cents. With 1.45M shares outstanding, the current market capitalization sits at 1.13B.

View a ticker or compare two or three

Compare

VRDN